Teva Pharmaceutical Halts Drug Production at Irvine, Calif., Plant

By PacConAdmin | November 1, 2021

Teva Pharmaceutical stopped drug manufacturing at its Irvine, Calif., facility following a recent FDA inspection that revealed lapses, including possible mold contamination caused by water leaks.
Source: Drug GMP Report

Posted in Drug GMP Report